Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a pill protect babies from stomach bugs? new vaccine trial in moms

NCT ID NCT07254728

First seen Nov 28, 2025 · Last updated May 09, 2026 · Updated 22 times

Summary

This early-stage study tested an oral (swallowed) norovirus vaccine in 76 healthy breastfeeding mothers to see if it is safe and can create protective antibodies that pass into breastmilk. The goal is to potentially protect both mothers and their nursing infants from the severe vomiting and diarrhea caused by norovirus. The trial focused on safety and immune response, not on preventing actual illness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NOROVIRUS INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • FCRN Clinical Trials Centre (Pty) Ltd

    Vereeniging, 1935, South Africa

  • Newtown Clinical Research Centre

    Johannesburg, 2001, South Africa

  • Progress Clinical Research Unit

    Honeydew, 2040, South Africa

  • Trident Clinical

    Kimberley, 8301, South Africa

  • WITS RHI Research Centre

    Hillbrow, 2001, South Africa

Conditions

Explore the condition pages connected to this study.